GlycoMimetics (GLYC) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GlycoMimetics Short Interest DataGlycoMimetics (GLYC) has a short interest of 1.71 million shares, representing 2.90% of the float (the number of shares available for trading by the public). This marks a 1.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 64,763 shares to cover all short positions.Current Short Interest1,710,000 sharesPrevious Short Interest1,680,000 sharesChange Vs. Previous Month+1.79%Dollar Volume Sold Short$358.59 thousandShort Interest Ratio1.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares64,532,000 sharesShort Percent of Float2.90%Today's Trading Volume1,049,686 sharesAverage Trading Volume64,763 sharesToday's Volume Vs. Average1,621% Short Selling GlycoMimetics? Sign up to receive the latest short interest report for GlycoMimetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLYC Short Interest Over TimeGLYC Days to Cover Over TimeGLYC Percentage of Float Shorted Over Time GlycoMimetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20251,710,000 shares $358.59 thousand +1.8%2.9%1 $0.21 5/15/20251,680,000 shares $419.66 thousand -8.2%2.9%4.6 $0.25 4/30/20251,830,000 shares $460.25 thousand -7.1%N/A1.3 $0.25 4/15/20251,970,000 shares $448.77 thousand -19.9%3.3%1.4 $0.23 3/31/20252,460,000 shares $516.60 thousand -4.7%4.2%1.8 $0.21 3/15/20252,580,000 shares $680.35 thousand -10.1%4.4%1.9 $0.26 2/28/20252,870,000 shares $780.07 thousand +30.5%4.9%2 $0.27 2/15/20252,200,000 shares $638 thousand +8.4%3.7%1.3 $0.29 1/31/20252,030,000 shares $544.45 thousand -9.4%N/A2.3 $0.27 1/15/20252,240,000 shares $568.06 thousand +3.2%N/A0.1 $0.25 Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20242,170,000 shares $540.33 thousand -2.7%N/A0.1 $0.25 12/15/20242,230,000 shares $532.52 thousand -14.2%N/A0.1 $0.24 11/30/20242,600,000 shares $901.94 thousand -31.6%N/A0.1 $0.35 11/15/20243,800,000 shares $1.58 million -32.6%N/A0.2 $0.42 10/31/20245,640,000 shares $2.29 million +208.2%N/A0.3 $0.41 10/15/20241,830,000 shares $278.89 thousand +11.6%N/A1.6 $0.15 9/30/20241,640,000 shares $277.16 thousand -9.9%N/A1.5 $0.17 9/15/20241,820,000 shares $309.40 thousand -5.7%N/A0.5 $0.17 8/31/20241,930,000 shares $340.26 thousand -16.5%N/A0.5 $0.18 8/15/20242,310,000 shares $413.95 thousand -25.7%N/A0.6 $0.18 7/31/20243,110,000 shares $674.87 thousand +9.1%N/A0.8 $0.22 7/15/20242,850,000 shares $883.50 thousand -44.2%N/A0.7 $0.31 6/30/20245,110,000 shares $1.44 million +190.3%N/A1.2 $0.28 6/15/20241,760,000 shares $462.88 thousand -15.8%N/A0.4 $0.26 5/31/20242,090,000 shares $566.39 thousand -10.7%N/A1.2 $0.27 5/15/20242,340,000 shares $631.80 thousand -61.6%N/A1.5 $0.27 4/30/20246,090,000 shares $10.96 million +102.3%N/A4.6 $1.80 4/15/20243,010,000 shares $6.79 million +89.3%N/A6.6 $2.26 3/31/20241,590,000 shares $4.77 million +6.7%N/A4.3 $3.00 3/15/20241,490,000 shares $3.81 million -4.5%N/A4.2 $2.56 2/29/20241,560,000 shares $4.51 million +9.1%N/A4.6 $2.89 2/15/20241,430,000 shares $4.42 million +43.3%N/A4.5 $3.09 1/31/2024997,900 shares $2.99 million +24.8%N/A3.5 $3.00 1/15/2024799,700 shares $2.49 million +40.3%N/A3.3 $3.11 12/31/2023570,000 shares $1.35 million -11.2%N/A2.9 $2.36 12/15/2023641,600 shares $1.27 million -23.7%N/A3.8 $1.98 11/30/2023841,200 shares $1.38 million -4.3%N/A7 $1.64 11/15/2023878,900 shares $1.22 million -1.6%N/A7.5 $1.39 10/31/2023893,500 shares $1.12 million -8.9%N/A7.3 $1.25 10/15/2023981,100 shares $1.39 million +4.3%N/A8.1 $1.42Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 9/30/2023940,300 shares $1.41 million -7.8%N/A8.2 $1.50 9/15/20231,020,000 shares $1.44 million -1.9%N/A8.8 $1.41 8/31/20231,040,000 shares $1.66 million -6.3%N/A7.6 $1.60 8/15/20231,110,000 shares $1.78 million -4.3%N/A6.6 $1.60 7/31/20231,160,000 shares $1.90 million -4.9%N/A5.1 $1.64 7/15/20231,220,000 shares $2.01 million -1.6%N/A5.2 $1.65 6/30/20231,240,000 shares $2.16 million +1.6%N/A5.1 $1.74 6/15/20231,220,000 shares $2.33 million -14.1%N/A4.3 $1.91 5/31/20231,420,000 shares $2.64 million +7.6%N/A4.5 $1.86 5/15/20231,320,000 shares $2.75 million -2.2%N/A2.8 $2.08 4/30/20231,350,000 shares $1.89 million -13.5%N/A1.3 $1.40 4/15/20231,560,000 shares $2.29 million -23.5%N/A1.2 $1.47 3/31/20232,040,000 shares $2.57 million -0.5%N/A1.5 $1.26 3/15/20232,050,000 shares $3.05 million -23.5%4.5%1.4 $1.49 2/28/20232,680,000 shares $4.13 million +92.8%5.8%1.8 $1.54 2/15/20231,390,000 shares $2.11 million +40.0%3.0%1 $1.52 1/31/2023992,600 shares $2.89 million +50.2%2.2%1 $2.91 1/15/2023660,700 shares $2.00 million +7.8%1.6%1 $3.02 12/30/2022613,000 shares $1.86 million +20.8%1.5%1.1 $3.03 12/15/2022507,300 shares $1.03 million -0.6%1.2%1.2 $2.04 11/30/2022510,200 shares $1.10 million -14.2%1.2%1.4 $2.16 11/15/2022594,500 shares $1.01 million +3.6%1.4%1.9 $1.70 10/31/2022574,100 shares $389.41 thousand +19.7%1.4%5.1 $0.68 10/15/2022479,700 shares $298.13 thousand +2.4%1.1%3.9 $0.62 9/30/2022468,700 shares $258.58 thousand -5.8%1.1%3.6 $0.55 9/15/2022497,300 shares $341.10 thousand -1.8%1.2%3.7 $0.69 8/31/2022506,300 shares $384.79 thousand +6.1%1.2%3.5 $0.76 8/15/2022477,300 shares $400.93 thousand -10.9%1.1%3.5 $0.84 7/31/2022535,500 shares $355.04 thousand -6.8%1.6%3.6 $0.66 7/15/2022574,500 shares $363.14 thousand +4.3%1.7%3.4 $0.63 6/30/2022551,000 shares $329.44 thousand -17.1%1.7%3.1 $0.60 6/15/2022664,400 shares $372.79 thousand +2.3%2.0%3.7 $0.56 5/31/2022649,500 shares $432.44 thousand +5.8%1.5%3.7 $0.67 5/15/2022613,700 shares $346.13 thousand -2.3%1.5%3.1 $0.56 4/30/2022628,300 shares $451.50 thousand +3.9%1.5%3 $0.72 4/15/2022605,000 shares $605 thousand -1.1%1.4%3 $1.00 3/31/2022612,000 shares $697.68 thousand -2.3%1.5%2.9 $1.14 3/15/2022626,400 shares $645.19 thousand -8.9%1.5%2.6 $1.03 2/28/2022687,600 shares $845.75 thousand +1.3%1.7%2.6 $1.23 2/15/2022678,600 shares $719.32 thousand -10.1%1.6%2.4 $1.06 1/31/2022754,700 shares $898.09 thousand +13.5%1.8%2.4 $1.19 1/15/2022665,200 shares $824.85 thousand +1.2%N/A2 $1.24 12/31/2021657,600 shares $946.94 thousand -2.7%1.6%1.9 $1.44 12/15/2021676,000 shares $1.03 million +1.8%1.6%1.1 $1.52 11/30/2021664,300 shares $1.12 million -10.2%1.6%1 $1.69 11/15/2021739,400 shares $1.58 million -0.5%1.8%1.1 $2.14 10/29/2021743,300 shares $1.42 million -12.7%1.8%1.2 $1.91 10/15/2021851,000 shares $1.68 million -21.9%2.1%1.3 $1.98 9/30/20211,090,000 shares $2.39 million +1.9%2.6%1.7 $2.19 9/15/20211,070,000 shares $2.29 million -2.7%2.6%2.1 $2.14Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 8/31/20211,100,000 shares $2.44 million -28.6%2.7%2.4 $2.22 8/13/20211,540,000 shares $3.05 million -6.7%3.7%3.2 $1.98 7/30/20211,650,000 shares $3.33 million No Change4.0%2.4 $2.02 7/15/20211,650,000 shares $3.35 million +7.1%4.0%2.3 $2.03 6/30/20211,540,000 shares $3.57 million -37.1%3.7%1.9 $2.32 6/15/20212,450,000 shares $6.32 million -11.6%5.9%3.2 $2.58 5/28/20212,770,000 shares $7.06 million +26.5%6.7%3.5 $2.55 5/14/20212,190,000 shares $5.52 million -11.0%5.3%2.4 $2.52 4/30/20212,460,000 shares $6.15 million +74.5%6.0%3 $2.50 4/15/20211,410,000 shares $3.71 million +6.8%3.4%1.6 $2.63 3/31/20211,320,000 shares $3.83 million +3.9%3.2%1.5 $2.90 3/15/20211,270,000 shares $4.20 million +18.7%3.2%1.5 $3.31 2/26/20211,070,000 shares $3.66 million +16.4%2.7%1.3 $3.42 2/12/2021919,100 shares $3.74 million +4.6%2.5%1.2 $4.07 1/29/2021878,800 shares $3.22 million -2.9%2.3%1.2 $3.66 1/15/2021904,700 shares $3.40 million -54.3%2.4%1.3 $3.76 12/31/20201,980,000 shares $7.50 million -21.7%5.3%3.2 $3.79 12/15/20202,530,000 shares $9.21 million +36.0%6.7%4.3 $3.64 11/30/20201,860,000 shares $6.81 million -5.6%4.9%3.7 $3.66 11/15/20201,970,000 shares $6.88 million +1.0%5.2%4.7 $3.49 10/30/20201,950,000 shares $5.62 million -11.4%5.2%5.6 $2.88 10/15/20202,200,000 shares $7.55 million +8.9%5.8%7.4 $3.43 9/30/20202,020,000 shares $6.20 million -5.6%5.4%5.2 $3.07 9/15/20202,140,000 shares $7.62 million -0.5%5.7%4.2 $3.56 8/31/20202,150,000 shares $7.93 million -2.7%5.7%2.8 $3.69 8/14/20202,210,000 shares $8.18 million -3.5%6.0%2.8 $3.70 7/31/20202,290,000 shares $9.02 million -7.7%6.2%2.9 $3.94 7/15/20202,480,000 shares $9.94 million -11.1%7.4%3.3 $4.01 GLYC Short Interest - Frequently Asked Questions What is GlycoMimetics' current short interest? Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 1,710,000 shares of GLYC short. 2.90% of GlycoMimetics' shares are currently sold short. Learn More on GlycoMimetics' current short interest. What is a good short interest ratio for GlycoMimetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GLYC shares currently have a short interest ratio of 1.0. Learn More on GlycoMimetics's short interest ratio. What is a good short interest percentage for GlycoMimetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.90% of GlycoMimetics' floating shares are currently sold short. Is GlycoMimetics' short interest increasing or decreasing? GlycoMimetics saw a increase in short interest in May. As of May 31st, there was short interest totaling 1,710,000 shares, an increase of 1.8% from the previous total of 1,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does GlycoMimetics' short interest compare to its competitors? 2.90% of GlycoMimetics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GlycoMimetics: Iterum Therapeutics PLC (2.99%), Pluri Inc. (0.71%), Shattuck Labs, Inc. (3.84%), ABVC BioPharma, Inc. (3.49%), Eagle Pharmaceuticals, Inc. (0.46%), Akari Therapeutics PLC (0.11%), Barinthus Biotherapeutics PLC Sponsored ADR (0.09%), Acrivon Therapeutics, Inc. (5.05%), Karyopharm Therapeutics Inc. (25.38%), Telomir Pharmaceuticals, Inc. (12.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short GlycoMimetics stock? Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GlycoMimetics? A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further. How often is GlycoMimetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Iterum Therapeutics Short Interest Pluri Short Interest Shattuck Labs Short Interest ABVC BioPharma Short Interest Eagle Pharmaceuticals Short Interest Akari Therapeutics Short Interest Barinthus Biotherapeutics Short Interest Acrivon Therapeutics Short Interest Karyopharm Therapeutics Short Interest Telomir Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLYC) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
